Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes of administration TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and tissue binding characteristics Combined formulation provides both immediate and sustained bioactivity Distribution studies suggest that while each peptide follows distinct pathways, injury sites tend to concentrate all three components, potentially enhancing local therapeutic effects through multiple mechanisms
Lyophilized peptides stored at -20C or below in their original sealed vials can last for years
5-Amino-1MQ for Cellular Metabolism Support The 5-amino-1mq peptide targets cellular energy metabolism by inhibiting NNMT (nicotinamide N-methyltransferase), an enzyme that often becomes overactive in fat tissue
Clinical Status: 5-Amino-1MQ is a research compound evaluated in preclinical and emerging human studies for obesity, insulin resistance, and metabolic health applications
Tirzepatide is a medication that shows the greatest amount of weight loss compared with liraglutide and semaglutide, but the best option for you should be discussed with your clinician
US$ 27.61
US$ 28.77
US$ 28.59
US$ 20.71
